Eli Lilly and Company

Science has been our calling from the beginning. Colonel Eli Lilly founded the company in 1876 and charged employees to “take what you find here and make it better and better.” More than 147 years later, we remain committed to his vision through every aspect of our business and the people we serve, starting with discovering the best treatments for those who take our medicines and extending to health care professionals, employees and the communities in which we live. Moreover, you can also count on the team at Lilly to be incredibly civic-minded, supporting our communities through philanthropy, volunteerism, and a creative and innovative can-do spirit.

When you’re on a mission to do what’s never been done before, you seek people willing to challenge the status quo of medicine. Those willing to relentlessly pursue what’s next, all in the name of health above all. #WeAreLilly

893 S Delaware St
Indianapolis, IN 46285

Discovery is
in our DNA

Exceptional people with an
extraordinary purpose.
Our values and commitment
have guided our success
for over 140 years.

Explore Careers

We are Lilly

Why do our employees love coming to work each and every day? Here’s what they have to say.

“Opportunity for growth is actually the biggest reason that I ended up hiring into Lilly.”

Kavita - Associate Director, Packaging Operations
“Lilly worked bery hard to be able to allow me to settle into my role, but they also had a great deal of consideration for my life outside of work.”

Adrian - Associate Director, IDM
“What we do matters, it matters to the people that we interact with. It matters to people in our families and it matters to people around the world.”

Cecile - Sr Director, Design Hub Foundations

39,000 global employees coming together from diverse backgrounds to create medicines that make life better for people around the world. Get to know us through our Powered by Purpose series.

View Stories

NEWS

Business

BioSpace Movers and Shakers, July 12

Biotech and pharma companies strengthen their leadership teams with new appointments.

July 11, 2019

5 min read

Alex Keown

Drug Development

Innovent Provide Key Results Update of Several Clinical Studies at 2019 ASCO Annual Meeting

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicines, presented the research data on the treatment of relapsed or refractory extranodal NK/T cell lymphoma with sintilimab, co-developed with Eli Lilly and Company and key data from six other clinical studies were presented at the 55th Annual Meeting of the American Society of Clinical Oncology by oral presentation and posters.

July 3, 2019

10 min read

FDA

U.S. Pharma and Biotech Companies Develop Therapies that Lead to ‘Health Independence.’

As fireworks illuminate the night skies across the United States this weekend in celebration of Independence Day, BioSpace takes a look at some of the highlights of the pharma industry from the first half of 2019 and earlier that provides millions of patients with the independence of health.

July 3, 2019

4 min read

Alex Keown

Career Advice

Top Life Science Companies Hiring Now in July

According to a BioSpace poll, over half (56%) of respondents are not happy with their current life sciences position. Are you one of the 56%? You deserve to be happy! Start working towards your happiness and check out job opportunities at these top companies!

July 1, 2019

1 min read

BioSpace Staff

Laboratory glassware containing chemical liquid, science research

Drug Development

The Clinical Catch-Up for Monday, July 1

Exiting the last week of June and heading into July, a number of companies announced results from ongoing clinical trials. Here’s a look.

June 28, 2019

3 min read

Mark Terry

Policy

Pharma Companies Sue Trump Administration Over Price Disclosure Mandate

The lawsuit was joined by Merck, Eli Lilly and Amgen. The companies claim the Department of Health and Human Services does not have the legal authority to force the companies to comply with the new rule.

June 17, 2019

3 min read

Alex Keown

Drug Development

Clinical Catch-up for June 10-14

Last week there were quite a few clinical trials whose data were presented. Many were at the American Diabetes Association 79th Scientific Sessions, while others were presented at separate meetings or independently. Here’s a look.

June 14, 2019

6 min read

Mark Terry

Drug Development

ADA Spotlight: Novo Nordisk, Boehringer Ingelheim, Eli Lilly and More

Almost 15,000 physicians, scientists, health care professionals and industry representatives from around the globe presented research, treatment recommendations and advances toward a diabetes cure at the American Diabetes Association’s 79th Scientific Sessions in San Francisco this week.

June 12, 2019

3 min read

Mark Terry

Drug Development

Eli Lilly’s Trulicity Significantly Decreases Cardiovascular Events, Still Lags Behind Novo Nordisk

Despite very positive results, the company’s shares were down 1.5% in premarket trading today. Vamil Divan, an analyst with Credite Suisse, wrote in a note to investors, that results “were fairly consistent across various patient subgroups and are clearly positive” for this class of drug, but “we believe investors may have been hoping for greater risk reduction.”

June 10, 2019

2 min read

Mark Terry

JOBS